Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-012-8 | CAS number: 16941-92-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Sensitisation data (human)
Administrative data
- Endpoint:
- sensitisation data (humans)
- Type of information:
- other: Occupational, observation
- Adequacy of study:
- key study
- Study period:
- Observation reported from 1984-1991
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Case report on only one individual.
Data source
Reference
- Reference Type:
- publication
- Title:
- Contact urticaria with anaphylactic reactions caused by occupational exposure to iridium salt
- Author:
- Bergman A, Svedberg U and Nilsson E
- Year:
- 1 995
- Bibliographic source:
- Contact Dermatitis 32, 14-17
Materials and methods
- Type of sensitisation studied:
- respiratory
- skin
- Study type:
- case report
- Principles of method if other than guideline:
- Patch testing performed on an individual with occupational respiratory and skin symptoms.
- GLP compliance:
- no
- Remarks:
- GLP not relevant to this type of study
Test material
- Reference substance name:
- Hexachloroiridic acid
- EC Number:
- 241-012-8
- EC Name:
- Hexachloroiridic acid
- Cas Number:
- 16941-92-7
- Molecular formula:
- Cl6Ir.2H
- IUPAC Name:
- hexachloroiridium(2-);hydron
- Test material form:
- other: 25% stock solution was diluted with deionised water containing NaCl and NaHCO3, final pH 7.5-8.0
- Details on test material:
- - Name of test material (as cited in study report): Iridium chloride
- Molecular formula (if other than submission substance): H2IrCl6
- Substance type: Technical product
- Physical state: In solution
- Analytical purity: no data
- Impurities (identity and concentrations): Measurements for 29 elemental impurities in the stock solution used for testing are reported, including those for rhodium, palladium, osmium and platinum. All are less that 200 ppm, except platinum (present at 310 ppm). "Insolubles" content of <1000 ppm.
- Composition of test material, percentage of components: no data
- Lot/batch No.: no data
- Expiration date of the lot/batch: no data
- Stability under test conditions: no data
- Storage condition of test material: no data
Constituent 1
Method
- Type of population:
- occupational
- Ethical approval:
- not specified
- Subjects:
- - Number of subjects exposed: 1
- Sex: male
- Age: 26
- Race: "white" - Clinical history:
- - History of allergy or causistics for study subject: no previous "medical record" [presumably no previous clinical history], no personal or family history of atopy, non-smoker.
- Symptoms, onset and progress of the disease: After 3 years of work, the patient developed a congested nose, rhinitis, a tendency to nasal ulceration, dyspnea [shortness of breath], a dry cough and eye irritation while at work. After around 2 years, the respiratory symptoms became worse to the extent that sporting activities were not possible in the evenings after work days (physical exercise without respiratory problems could be performed on non-working days). Occasional development of urticaria on the wrists around 5 minutes after direct skin contact with coating solutions [see below, under "Exposure history"] then began to occur, and periodically, urticaria also appeared at various friction sites such as the waist and ankles; this receded within hours after cessation of exposure.
- Exposure history: Employment as a process operator in an electrochemical factory manufacturing titanium anodes, which were coated in various metal salts of the platinum group dissolved in hydrochloric acid. The coating solution was sprayed onto the anodes automatically. The workplace had "insufficient ventilation" and poor enclosure of the process equipment, and so aerosols were able to spread into the working zone of the operators. Operators' skin could be exposed to the coating solution during repair of the supply lines to the spray mechanism. The major air contaminants were thought to be hydrochloric acid and "metal salts".
- Aggravating factors both in home and workplace: None reported.
- Family history: No family history of atopy.
- Medical history (for respiratory hypersensitivity): None
- Any other allergic or airway disorders: None
- Smoking history: Non-smoker - Controls:
- 14 workers at the same factory expsoed to salts of the platinum group metals (5 reported a tendency to occasional work-related nasal ulceration, 4 reported uncharacteristic skin symptoms (not contact urticaria), 3 reported varying degrees of nasal congestion and occasional work-related respiratory symptoms, 9 reported no symptoms). None exhibited skin reactions when prick-tested with an iridium salt [presumably hexachloroiridic acid]; 2 with the "most pronounced symptoms" underwent scratch tests with an iridium salt [presumably hexachloroiridic acid] - again no skin reactions were seen.
- Route of administration:
- dermal
- Details on study design:
- TYPE OF TEST(S) USED: prick test; also a skin test to the highest test concentration
ADMINISTRATION
- Type of application: by pricking and to the skin (without pricking) for the highest test concentration only
- Vehicle / solvent: water with sodium chloride and sodium bicarbonate buffer to result in a pH of 7.5-8.0
- Concentrations: 0.26 ng/ml to 0.5 mg/ml
- Volume applied: No data
- Testing/scoring schedule: After 15 minutes
- Removal of test substance: no data
EXAMINATIONS
- Grading/Scoring system: observation; measurement of weal and flare where appropriate
Results and discussion
- Results of examinations:
- SYMPTOMS
- Frequency, level, duration of symptoms observed: The highest prick test concentration produced a weal (4 mm) and flare (30 mm); the next concentration down (0.05 mg/ml) produced erythema (10 mm); lower concentrations produced no reaction. The skin test (without pricking) produced 4 "follicaular urtications" surrounded by a flare (20 mm).
RESULT OF CASE REPORT: The prick/skin-test reactions and occupational symptoms were considered indicative of allergy (possibly Type I hypersensitivity) to hexachloroiridic acid. Symptoms disappeared upon cessation of employment in the factory.
OTHER RESULTS: Hypersensitivity to the platinum impurity in the iridium-based test solution was discounted by skin prick tests with diammonium hexachloroplatinate solution - platinum concentrations were >1000 times that in the iridium test solution that had previously produced a reaction indicative of sensitisation. No reaction was seen.
Applicant's summary and conclusion
- Conclusions:
- A published paper describes a case of hypersensitivity to hexachloroiridic acid (in the absence of sensitisation to platinum), following occpational exposure.
- Executive summary:
A published paper describes an individual exhibiting occupationally-related respiratory and skin symptoms. He had been employed for several years as a process operator in an electrochemical factory manufacturing titanium anodes and was exposed to airborne aerosols of metal salts of the platinum group and hydrochloric acid. Prick and skin testing with various concentrations of hexachloroiridic acid indicated hypersensitivity (in the absence of sensitisation to platinum).
Cessation of employment resulted in the disappearance of symptoms. The investigators diagnosed probable Type I allergy to this iridium salt.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.